113 related articles for article (PubMed ID: 27984393)
1. Etiology of Malignant Pleural Effusion and Utilization of Diagnostic and Therapeutic Procedures: A Nationwide Analysis.
Chatterjee K; Goyal A; Kakkera K; Meena N
J Bronchology Interv Pulmonol; 2017 Jan; 24(1):e10-e12. PubMed ID: 27984393
[No Abstract] [Full Text] [Related]
2. A national survey of oncologist and chest physicians' attitudes towards empirical anti-oestrogen therapy, early pleurodesis and preference of sclerosing agent in malignant breast and ovarian pleural disease.
Medford AR; Maskell NA
Palliat Med; 2005 Jul; 19(5):430-1. PubMed ID: 16111068
[No Abstract] [Full Text] [Related]
3. Procedures Performed during Hospitalizations for Malignant Pleural Effusions: Data from the 2012 National Inpatient Sample.
Fortin M; Taghizadeh N; Tremblay A
Respiration; 2018; 95(4):228-234. PubMed ID: 29414821
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of a new small-bore percutaneous pleural catheter used for treatment of malignant pleural effusions in ECOG PS 3-4 patients.
Filosso PL; Sandri A; Felletti G; Ruffini E; Lausi PO; Oliaro A
Eur J Surg Oncol; 2011 Dec; 37(12):1093-8. PubMed ID: 21963043
[TBL] [Abstract][Full Text] [Related]
5. Healthcare Costs and Utilization among Patients Hospitalized for Malignant Pleural Effusion.
Shafiq M; Ma X; Taghizadeh N; Kharrazi H; Feller-Kopman DJ; Tremblay A; Yarmus LB
Respiration; 2020; 99(3):257-263. PubMed ID: 32155630
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
Chella A; Ribechini A; Dini P; Adamo C; Mussi A; Angeletti CA
Minerva Chir; 1994 Nov; 49(11):1077-82. PubMed ID: 7708227
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.
Porcel JM; Solé C; Salud A; Bielsa S
Lung; 2017 Dec; 195(6):775-779. PubMed ID: 28900718
[TBL] [Abstract][Full Text] [Related]
8. Management of malignant pleural effusion secondary to breast cancer: talc pleurodesis and pleuroperitoneal shunting.
Saute M
Isr J Med Sci; 1995; 31(2-3):160-2. PubMed ID: 7744586
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
10. Important prognostic factors for survival in patients with malignant pleural effusion.
Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
[TBL] [Abstract][Full Text] [Related]
11. Video-assisted management of malignant pleural effusion in breast carcinoma.
Gasparri R; Leo F; Veronesi G; De Pas T; Colleoni M; Maisonneuve P; Pelosi G; Galimberti V; Spaggiari L
Cancer; 2006 Jan; 106(2):271-6. PubMed ID: 16342163
[TBL] [Abstract][Full Text] [Related]
12. [Thoracentesis and pleurodesis in the treatment of pleural effusion. Personal experience].
Pisello F; Geraci G; Sciumè C; Li Volsi F; Platia L; Facella T; Romeo M; Modica G
G Chir; 2008; 29(6-7):299-304. PubMed ID: 18544270
[TBL] [Abstract][Full Text] [Related]
13. Investigation on the epidemiological significance of detailed cancer data--preliminary results.
Steinitz R; Costin C
Recent Results Cancer Res; 1972; 39():7-28. PubMed ID: 4352667
[No Abstract] [Full Text] [Related]
14. Massive pleural effusion: malignant and nonmalignant causes in 46 patients.
Maher GG; Berger HW
Am Rev Respir Dis; 1972 Mar; 105(3):458-60. PubMed ID: 4501503
[No Abstract] [Full Text] [Related]
15. Pleurodesis with recombinant tumour necrosis factor in gynaecological neoplasms.
Rauthe G; Sistermanns J
Eur J Gynaecol Oncol; 1998; 19(2):108-12. PubMed ID: 9611046
[TBL] [Abstract][Full Text] [Related]
16. Images in clinical medicine. Effect of intrapleural streptokinase on a loculated malignant pleural effusion.
Maskell NA; Gleeson FV
N Engl J Med; 2003 Apr; 348(14):e4. PubMed ID: 12672879
[No Abstract] [Full Text] [Related]
17. Rapid pleurodesis in symptomatic malignant pleural effusion.
Yildirim E; Dural K; Yazkan R; Zengin N; Yildirim D; Gunal N; Sakinci U
Eur J Cardiothorac Surg; 2005 Jan; 27(1):19-22. PubMed ID: 15621465
[TBL] [Abstract][Full Text] [Related]
18. [Results of phase III clinical trial of Pseudomonas jinanensis vaccine injection (PVI) in the treatment of malignant pleural effusion].
Wang J; Zhang H; Wang Y
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):458-60. PubMed ID: 8698003
[TBL] [Abstract][Full Text] [Related]
19. Management of malignant pleural effusion associated with trapped lung syndrome.
Qureshi RA; Collinson SL; Powell RJ; Froeschle PO; Berrisford RG
Asian Cardiovasc Thorac Ann; 2008 Apr; 16(2):120-3. PubMed ID: 18381869
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors of 30-Day Mortality After Palliative Procedures in Patients with Malignant Pleural Effusion.
Abrao FC; de Abreu IR; Fogarolli M; Caxeiro G; Bezerra CB; de Cerqueira Cesar FP; Rocha PS; Younes RN
Ann Surg Oncol; 2015 Nov; 22(12):4083-8. PubMed ID: 25758190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
